Clinical Trial Update: Ticagrelor Administered as Standard Tablet or Orodispersible Formulation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ticagrelor given as standard tablet vs orodispersible formulation in ST-elevation MI and NSTEMI; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Azienda Ospedaliero Universitaria di Sassari | Conditions: ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI | Phase 3 | Status: COMPLETED | Results posted: 2021-09-08